Is EVO or FBLG more undervalued in 2026?

CirclFi compares Evotec SE (EVO) and FibroBiologics, Inc. (FBLG) using 13 institutional-grade valuation models. EVO has a Quality of Company score of 6.2/10 while FBLG scores 4.1/10.

Which is a better buy — EVO or FBLG?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do EVO and FBLG valuations compare?

EVO at $3.07 and FBLG at $1.16 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

EVO vs FBLG Valuation Comparison 2026 — Intrinsic Value Analysis

EVO

Pharmaceutical Preparations

Evotec SE

Quality

6.2

out of 10

Value Trap

SAFE

Price

$3.07

Last close

Models

10/13

Active

FBLG

Pharmaceutical Preparations

FibroBiologics, Inc.

Quality

4.1

out of 10

Value Trap

SAFE

Price

$1.16

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	EVO Fair Value	EVO Upside	FBLG Fair Value	FBLG Upside
Bayesian DCF	Intrinsic	$0.22	-92.8%	$0.22	-80.9%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.13	-63.1%	—	—
Dynamic NAV	Asset-Based	$1.58	-48.5%	$1.70	+46.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for EVO vs FBLG — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

EVO vs FBLG — Which Stock Is More Undervalued?

EVO scores higher with a 6.2/10 quality rating vs FBLG's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Evotec SE (EVO) and FibroBiologics, Inc. (FBLG) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

EVO currently trades at $3.07 with a QOC of 6.2/10, while FBLG trades at $1.16 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).